Supply of medicinal products for chemotherapy and clinical oncology programs
Dostawa produktów leczniczych do realizacji chemioterapii i programów onkologia kliniczna
Poland · Dąbrowa Górnicza · how to bid here →
Your path to submission
- Deadline: 23 September at 08:00 — 7 days left.
- You submit on eZamówienia — not here and not by e-mail. ↗ Submission via eZamówienia: account required; above the EU threshold a qualified signature, nationally the 'trusted signature' often suffices — check the wording. Sort out account and signature first — not on submission day.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (671 awards, most recently September 2026) — the next award is due around October 2026 by that rhythm. The last award went to Zakład Techniki Medycznej "TECH-MED" Sp. z o.o..n = 671
- 50% of this buyer's awards went to companies that had already won here before (1,023 awards since 2018, spread over 456 companies). 50% went to new names.n = 1,023 awards since 2018
- 28% of the bids received came from small and medium-sized enterprises (134 procedures with a bid mix). Sector: 50%.n = 134
- The median procedure drew 3 bids (490 procedures with a bid count); 30% ended with a single bidder. Sector: median 3 bids.n = 490
- 3% of awards went to companies from abroad (1,023 awards with a known winner country). Sector average: 4%.n = 1,023
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 15/09/2026.
Foreign bidders
In Poland · Medical equipment & pharma, 5,178 contracts went to foreign companies over the last 3 years (of 274,095 recorded awards) — mostly from Germany, France, Czechia.
Typical field: median 3 (from 393 awards).
What the buyer is looking for
1. 1. The subject of the contract is the supply of medicinal products for the implementation of chemotherapy and clinical oncology programs. The subject-matter of the contract is divided into 3 lots/packages, each of which is a separate subject-matter of the contract: Dexamethasoni phosphas 4mg/ml amp. 1 ml 2. A detailed description of the subject of the contract can be found in Annex 1a to the FTZ. 3. The subject of the contract was quantified on the basis of portions which are: tubes, ampoule bottles, vials, tablets, etc. The Contractor shall present medicinal products whose collective packaging does not exceed 100 items and shall exclude the so-called ‘hospital packs’ for pricing. 4. The Ordering Party allows the replacement of equivalent forms of the drug, e.g.: Solution for infusion, solution for injection, concentrate for solution for injection or tablets, film-coated tablets,…
Show full description
… capsules. 5. The Ordering Party requires that the offered medicines be included in the list of medicines reimbursed on the basis of the Regulation of the Minister of Health valid on the day of submission of tenders, and the price offered may not exceed the amount of the . financing limit. 6. The subject and conditions of performance of this contract must comply with the Pharmaceutical Law Act of 6 September 2001 and other applicable legal provisions in this respect. 4. The Contracting Authority does not provide for the possibility of awarding contracts referred to in Art. 1 point 8 of the PPL Act. 2. 1. The subject of the contract is the supply of medicinal products for the implementation of chemotherapy and clinical oncology programs. The subject-matter of the contract is divided into 3 lots/packages, each of which is a separate subject-matter of the contract: Amivantamabum 2. A detailed description of the subject of the contract can be found in Annex 1a to the FTZ. 3. The subject of the contract was quantified on the basis of portions which are: tubes, ampoule bottles, vials, tablets, etc. The Contractor shall present medicinal products whose collective packaging does not exceed 100 items and shall exclude the so-called ‘hospital packs’ for pricing. 4. The Ordering Party allows the replacement of equivalent forms of the drug, e.g.: Solution for infusion, solution for injection, concentrate for solution for injection or tablets, film-coated tablets, capsules. 5. The Ordering Party requires that the offered medicines be included in the list of medicines reimbursed on the basis of the Regulation of the Minister of Health valid on the day of submission of tenders, and the price offered may not exceed the amount of the . financing limit. 6. The subject and conditions of performance of this contract must comply with the Pharmaceutical Law Act of 6 September 2001 and other applicable legal provisions in this respect. 4. The Contracting Authority does not provide for the possibility of awarding contracts referred to in Art. 1 point 8 of the PPL Act. 3. 1. The subject of the contract is the supply of medicinal products for the implementation of chemotherapy and clinical oncology programs. The subject-matter of the contract is divided into 3 lots/packages, each of which is a separate subject-matter of the contract: Lazertinib tabl. 2. A detailed description of the subject of the contract can be found in Annex 1a to the FTZ. 3. The subject of the contract was quantified on the basis of portions which are: tubes, ampoule bottles, vials, tablets, etc. The Contractor shall present medicinal products whose collective packaging does not exceed 100 items and shall exclude the so-called ‘hospital packs’ for pricing. 4. The Ordering Party allows the replacement of equivalent forms of the drug, e.g.: Solution for infusion, solution for injection, concentrate for solution for injection or tablets, film-coated tablets, capsules. 5. The Ordering Party requires that the offered medicines be included in the list of medicines reimbursed on the basis of the Regulation of the Minister of Health valid on the day of submission of tenders, and the price offered may not exceed the amount of the . financing limit. 6. The subject and conditions of performance of this contract must comply with the Act of
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Urtica Sp. z o.o. | 23 | 2024–2026 |
| Salus International Sp. z o.o. | 21 | 2024–2026 |
| ANMAR Sp. z o.o. | 16 | 2024–2026 |
| Fresenius Kabi Polska Sp. z o.o. | 14 | 2021–2026 |
| Stryker Polska Sp. z o.o. | 14 | 2021–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on e-Zamówienia (Polen) → Registration, signature, fees — from the operator's bidder manual.